Skip to main content

Table 1 Demographics and pathologic characteristics of the study subjects.

From: Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer

  N = 96
Age (mean ± SD) 65.2 ± 9.1
Sex (M:F) 1:1.04
Operation  
  Whipple's operation 20 (20.8%)
  PPPD 39 (40.6%)
  Distal 30 (31.3%)
  Total 6 (6.3%)
Adjuvant chemotherapy 87 (90.6%)
  Gemcitabine 56 (58.3%)
  5-FU 21 (21.9%)
  Unknown 10 (10.4%)
Recurrence 58 (60.4%)
  Local 23 (24.0%)
  Distant 50 (52.1%)
Follow up (median, months) 14.3 (range, 2.9-45.9)
R status  
  R0 76 (79.2%)
  R1 14 (14.6%)
  R2 6 (6.3%)
AJCC 7th staging  
  Stage IA 3 (3.1%)
  Stage IB 0
  Stage IIA 41 (42.7%)
  Stage IIB 50 (52.1%)
  Stage III 1 (1.0%)
  Stage IV 1 (1.0%)
Histologic differentiation  
  Well differentiated 3 (3.1%)
  Moderately differentiated 84 (87.5%)
  Poorly differentiated 9 (9.4%)
Perineural invasion 83 (86.5%)
Endolymphatic invasion 39 (40.6%)
Endovenous invasion 25 (26.0%)